Where Tech Meets Bio
Latest News
A research team at Fujita Health University has developed a precision genome-editing approach to modulate levels of mutant mitochondrial DNA (mtDNA) in patient-derived stem cells, …
Read More
Khondrion Secures €5M to Advance Small Molecule Therapy Toward Phase 3 Trial
Khondrion, a clinical-stage biotech company focused on primary mitochondrial disease (PMD), has secured up to €5M in Innovation Credit from the Netherlands Enterprise Agency, alongside …
Read More
Iktos Brings its Gen-AI Drug Design Platform to AWS Marketplace
Iktos, a company developing AI and robotic technologies for medicinal chemistry and small molecule drug design, has expanded its collaboration with Amazon Web Services (AWS) …
Read More
Latest News
Crown Bioscience Shows 3D Bone Marrow Model to Improve Blood Cancer Drug Testing and Reduce Animal Use
Moderna to Onboard R&D Teams to Benchling Platform for AI-Driven Research Integration
Startup Working with Italian Hospitals Raises €2.2M to Structure Medical Reports into Care Plans
North Bristol NHS Trust Becomes Reference Site for FUJIFILM’s Digital Pathology Platform
Inductive Bio Raises $25M to Scale AI Platform for Predicting Drug Behavior Before Synthesis
Flagship Launches Etiome with $50M to Use AI for Stage-Specific Drug Target Discovery
Latest Insights
by Sai Bhamidipati
The Future of Advanced Therapeutics: Opportunities and Challenges
The biopharmaceutical landscape is transforming with the advent of advanced therapeutics, including mRNA vaccines, gene therapies, and personalized medicine. These innovative treatments offer unprecedented opportunities …
Read More
by Thomas Fessard
Chemistry CROs at a Crossroads: How SpiroChem Is Adapting to Market Shifts in 2025 and Beyond
As we approach 2025, the role of chemistry Contract Research Organizations (CROs) is undergoing profound transformation. Chemistry is no longer considered a commodity but an …
Read More
How AI, Graphs, and GraphRAG Are Set to Revolutionize Alzheimer's Gene Research and Treatment
by Dominik Tomicevic
Novotech Report: Over 800 Global IPF Trials Since 2020, Led by Asia-Pacific
by BiopharmaTrend
Report: Nearly 80% of Life Sciences Leaders Considering Virtual Models for Observational Research
by BiopharmaTrend
AI in Drug Safety: From Concept to Reality, The Industry's Path Forward
by Dr. Karthik Muthusamy
Marking the Path Ahead: Integrating Oncology Biomarkers Into Clinical Development
by Bea Mann, PhD
Combination Therapies May Be the Future of Oncology – How Can We Navigate Development Challenges Today?
by Andreas Dreps, Bea Mann, PhD
The Future of Advanced Therapeutics: Opportunities and Challenges
by Sai Bhamidipati
What CROs Cite as Their Top Clinical Trial Challenges and How They Plan to Overcome Them in 2025
by Megan Deegan
From Our Partners
Sponsored by
OPTIC
AI Is Key to Democratizing Drug Discovery
Sponsored by
Lantern Pharma
How AI Empowers Biomarker-Driven Clinical Trials
Sponsored by
Trialize
Unlocking Interoperability with AI: How This Company is Building a New Framework for Clinical Trials
Sponsored by
SpiroChem
Chemistry CROs at a Crossroads: How SpiroChem Is Adapting to Market Shifts in 2025 and Beyond
Partner Events

London Biotechnology Show 2025
Event Date: June 18, 2025 - June 19, 2025
Location: United Kingdom (Hall N7 & N8 Bett Global, Excel London, Royal Victoria Dock, 1 Western Gateway, London, UK, England, GB, E16 1XL)
Website: Link
Promo Code: 4CPHAK
Read more ›››

Global Clinical Trials Connect 2025
Promo Code: GCTC10 (valid till 2025-05-28)
Read more ›››

The 12th Aging Research & Drug Discovery Meeting The 11th Aging Research & Drug Discovery Meeting
Event Date: Aug. 25, 2025 - Aug. 29, 2025
Location: Denmark (Ceremonial Hall, University of Copenhagen)
Website: Link
Case Studies
Sponsored by
Lantern Pharma
Powering Cancer Drug Discovery and Development Using the Artificial Intelligence and Machine Learning Platform RADR®
Sponsored by
Biocompare
Biocompare: Offline Order Attribution Analysis Helps Demonstrate Marketing Effectiveness
Sponsored by
Cyclica
Cyclica's Chemical Probes for DCAF1
Sponsored by
Roivant Sciences
QUAISAR Computational Platform for Designing Targeted Protein Degraders
Sponsored by
RECEPTOR.AI
ArtiDock from Receptor.AI: Next-generation AI Docking That Beats DiffDock and AlphaFold-latest
Sponsored by
Kymera Therapeutics
Identifying High Impact Tissue Sparing E3 Ligases and Their Binders
Sponsored by
Trialize
Revolutionizing Clinical Trials: How AI and Automation Reduced Study Build Time from Months to Days
Sponsored by
RECEPTOR.AI
AI Becomes a Drop-in Replacement for Docking
Interviews
[Interview] This Company Brings Quantum Tech Into Protein Design
Rethinking Clinical Trials: Tim Smith on Medable’s Approach to Speed and Efficiency
A Look at Longevity Industry: Interview with Dr. Eric Leire, CEO of Genflow Biosciences
The Synergistic Potential of AI and Synthetic Biology: Interview with S&P Global’s Miriam Fernández
Most Read
How Big Pharma Adopts AI To Boost Drug Discovery
Six AI-driven Drug Discovery Companies Enabling Precision Oncology
Insilico Medicine’s Generative AI Patent Provides Advantage in AI Drug Discovery Race
10 Companies Applying AI for Biologics Discovery